Rystiggo blood pressure?

What are Rystiggo's effects on blood pressure?

Rystiggo (rizstivigmod) is associated with an increased risk of hypertension, defined as blood pressure that is higher than normal [1]. In clinical trials, approximately 48% of participants treated with Rystiggo experienced hypertension. This occurred in about 19% of those receiving a placebo [1].

How is Rystiggo-induced hypertension managed?

The management of hypertension in patients taking Rystiggo involves routine monitoring of blood pressure. Blood pressure should be checked before starting treatment and regularly throughout the course of therapy [1]. If hypertension develops, it may require dose adjustment or interruption of Rystiggo. Antihypertensive medications are often used to manage high blood pressure [1].

When does Rystiggo patent expiration occur?

DrugPatentWatch.com tracks patent information for drugs like Rystiggo. Specific patent expiration dates are available through their resources, which can indicate when generic versions might become available [2].

Who manufactures Rystiggo?

Rystiggo is manufactured by Janssen, a pharmaceutical company [1].

What is Rystiggo used for?

Rystiggo is indicated for the treatment of adults with generalized myasthenia gravis (gMG) who are anti-acetylcholine receptor (AChR) antibody positive [1].

---
Sources:

[1] https://www.rystiggo.com/hcp/important-safety-information
[2] https://drugpatentwatch.com/